Neutrophil/Lymphocyte ratio has no predictive or prognostic value in breast cancer patients undergoing preoperative systemic therapy

BACKGROUND: The primary goal of preoperative systemic treatment (PST) in patients with breast cancer is downsizing of tumors to enhance the rate of breast conserving surgery. Additionally, preoperative systemic treatment offers the possibility to assess for chemosensitivity of early stage disease. I...

Descripción completa

Detalles Bibliográficos
Autores principales: Suppan, Christoph, Bjelic-Radisic, Vesna, La Garde, Marlen, Groselj-Strele, Andrea, Eberhard, Katharina, Samonigg, Hellmut, Loibner, Hans, Dandachi, Nadia, Balic, Marija
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4696229/
https://www.ncbi.nlm.nih.gov/pubmed/26715527
http://dx.doi.org/10.1186/s12885-015-2005-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4696229/
https://www.ncbi.nlm.nih.gov/pubmed/26715527
http://dx.doi.org/10.1186/s12885-015-2005-3

Ejemplares similares